My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia
NCT00801580
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Lymphoid Leukemia
Interventions
DRUG:
doxorubicin liposomal
Sponsor
University of Bologna